He has a degree and PhD in pharmacology from Queens' College, Cambridge and University College London , respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017. Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience , ACS Pharmacology & Translational Science and Frontiers in Pharmacology.

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. He was the 2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Society (ICRS), respectively.

ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to industry (GSK, Takada, and Firmenich) which have recently been enhanced through him being awarded a Royal Society

carried out his Ph.D. at King’s College London, supported by an AJ Clark Ph.D. studentship from the British Pharmacological Society. as Chief Scientific Officer, a contract research organization specializing in molecular and cellular pharmacology several pre-clinical drug discovery projects for both GPCR and non-GPCR targets, using its expertise in pharmacology

, a corresponding member of NC-IUPHAR, a member of the Faculty of 1000 and an elected Fellow of the British Pharmacological Society (BPS). Sexton’s awards include the ASCEPT Lecturer award, Endocrine Society (Australia) Senior Plenary award , Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research Excellence award.

division) and an elected Fellow of the British Pharmacological Society (BPS). Sexton’s awards include the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Lecturer award, Endocrine Society of Australia Senior Plenary award, Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research Excellence award.

I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Pharmacological Society, and in 2021 he was elected a Fellow of the Australian Academy of Science for In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Pharmacological Society, and in 2021 he was elected a Fellow of the Australian Academy of Science for In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Pharmacological Society, and in 2021 he was elected a Fellow of the Australian Academy of Science for In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric Cannabinoid Receptor Pharmacology Devane Young Investigator Award from the International Cannabinoid Research Society (ICRS). Robert and his lab have been interested in the molecular pharmacology of cannabinoids for nearly 10 years

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics Khaled Abdelrahman on the web University of British Columbia Twitter PubMed Google Scholar Dr.

Applying Pharmacology to Drug Discovery Dr. Pharmacology is a unique discipline and is critical to drug discovery. What makes each drug type unique to therapeutic pharmacology? 3. Modules: Week 1 - Fundamentals of Pharmacology Week 2 - Characterizing Agonists Week 3 - Characterizing Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta,

Advanced data analysis for GPCR pharmacology Dr. Understanding the pharmacology data analysis framework we use for GPCRs. Module 2 - Quantifying agonist pharmacology and biased agonism. Module 3 - Antagonist pharmacology and binding assay analysis. Samuel Hoare Sam Hoare is a pharmacology data analyst with 30 years experience in GPCR pharmacology.

Principles of Pharmacology in Drug Discovery I Dr. In general, registrants will receive a comprehensive understanding of the unique science of pharmacology Registrants will learn: Essentials of measuring pharmacologic activity of ligands (affinity, efficacy Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta, My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

< GPCR News < GPCRs in Oncology and Immunology Biochemical pharmacology of adenylyl cyclases in cancer Published date October 1, 2024 Abstract "Globally, despite extensive research and pharmacological advancement

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

Principles of Pharmacology in Drug Discovery II Dr. Modules Lecture 1: The Eyes to See- The Importance of Pharmacologic Assays. Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta, then moved to the University of North Carolina School of Medicine where currently I am a Professor of Pharmacology My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology Integrated approach combined network pharmacology and molecular docking to identify and validate the underlying pharmacological mechanisms. Fumitaka Kawakami, Motoki Imai, Aman Tedasen Tags ADME , Cancer , GPCRs , Molecular Docking , Network pharmacology

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT)

Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones by the attribution of many awards and distinctions including his election as a fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental

Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones by the attribution of many awards and distinctions including his election as a fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental

Graciela Pineyro is a professor of pharmacology at the department of pharmacology and physiology of the She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain.

< GPCR News < GPCRs in Oncology and Immunology Pharmacological inhibition of neuropeptide Y receptors This abundance is exploited for cancer imaging, but there is interest in pharmacological inhibition of

Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological